Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance.
Schuler M, Hense J, Darwiche K, Michels S, Hautzel H, Kobe C, Lueong S, Metzenmacher M, Herold T, Zaun G, Laue K, Drzezga A, Theegarten D, Nensa F, Wolf J, Herrmann K, Wiesweg M. Schuler M, et al. Among authors: herrmann k. J Nucl Med. 2024 Jun 3;65(6):851-855. doi: 10.2967/jnumed.123.266979. J Nucl Med. 2024. PMID: 38575188 Clinical Trial.
SPECT/CT.
Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, Scheidhauer K, Wester HJ, Rummeny EJ, Schwaiger M, Drzezga A. Buck AK, et al. Among authors: herrmann k. J Nucl Med. 2008 Aug;49(8):1305-19. doi: 10.2967/jnumed.107.050195. Epub 2008 Jul 16. J Nucl Med. 2008. PMID: 18632825 Free article.
PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma.
Fendler WP, Lehmann M, Todica A, Herrmann K, Knösel T, Angele MK, Dürr HR, Rauch J, Bartenstein P, Cyran CC, Hacker M, Lindner LH. Fendler WP, et al. Among authors: herrmann k. J Nucl Med. 2015 Apr;56(4):530-7. doi: 10.2967/jnumed.114.152462. Epub 2015 Feb 26. J Nucl Med. 2015. PMID: 25722445 Free article.
PSMA Ligands for PET Imaging of Prostate Cancer.
Schwarzenboeck SM, Rauscher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, Afshar-Oromieh A, Herrmann K, Eiber M. Schwarzenboeck SM, et al. Among authors: herrmann k. J Nucl Med. 2017 Oct;58(10):1545-1552. doi: 10.2967/jnumed.117.191031. Epub 2017 Jul 7. J Nucl Med. 2017. PMID: 28687599 Free article. Review.
11C-MET PET/MRI for detection of recurrent glioma.
Deuschl C, Kirchner J, Poeppel TD, Schaarschmidt B, Kebir S, El Hindy N, Hense J, Quick HH, Glas M, Herrmann K, Umutlu L, Moenninghoff C, Radbruch A, Forsting M, Schlamann M. Deuschl C, et al. Among authors: herrmann k. Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):593-601. doi: 10.1007/s00259-017-3916-9. Epub 2017 Dec 28. Eur J Nucl Med Mol Imaging. 2018. PMID: 29282517
Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients: Preliminary results.
Sarabhai T, Tschischka A, Stebner V, Nensa F, Wetter A, Kimmig R, Forsting M, Herrmann K, Umutlu L, Grueneisen J. Sarabhai T, et al. Among authors: herrmann k. Clin Imaging. 2018 May-Jun;49:163-168. doi: 10.1016/j.clinimag.2018.03.009. Epub 2018 Mar 13. Clin Imaging. 2018. PMID: 29554613
CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor.
Zaun G, Schuler M, Herrmann K, Tannapfel A. Zaun G, et al. Among authors: herrmann k. Dtsch Arztebl Int. 2018 Mar 9;115(10):157-162. doi: 10.3238/arztebl.2018.0157. Dtsch Arztebl Int. 2018. PMID: 29587959 Free PMC article. Review.
1,401 results